Mr. Gerstein was a Senior Portfolio Manager and Partner at BlueMountain from 2004 – 2016, and currently serves as a Senior Advisor, as a member of the Firm’s Valuation Committee, and as a Director of several BlueMountain hedge funds. During Mr. Gerstein’s active tenure he oversaw the Volatility and Fixed Income Arbitrage Strategies, Risk, and was based in our London office for a time as CEO of BlueMountain Europe. Prior to joining BlueMountain, Mr. Gerstein was a Vice President and Head of U.S. Investment Grade Credit Derivatives Trading at Goldman Sachs. Over a 10 year career at Goldman, Mr. Gerstein held several other senior positions including Head of U.S. Agency Bond Trading and in Interest Rate Derivatives Marketing. Prior to that, Mr. Gerstein was a Vice President of Interest Rate Derivatives Marketing at J.P. Morgan. Mr. Gerstein is a member of the MIT Corporation Development Committee and the Board of Trustees at Blythedale Children’s Hospital in Valhalla, NY. He earned an M.B.A. from the MIT Sloan School of Management and a B.S. in Economics from the Massachusetts Institute of Technology.